AQEMIA (AI x Drug Discovery) Email Format

Biotechnology ResearchÎle-de-france, France51-200 Employees

AQEMIA (AI x Drug Discovery) is a biotechnology research company focused on discovering novel medicines, with a particular emphasis on oncology. The company uses a physics-based, generative AI platform to design drug candidates without relying on existing experimental data. AQEMIA maintains a rapidly expanding portfolio of proprietary programs and engages in collaborations with major pharmaceutical companies; its lead programs are undergoing in vivo optimization. Headquartered in Paris, France (1 Boulevard Pasteur, 75015), AQEMIA also operates a London office, and the team is reported to number between 51 and 200 employees. The company participates in the French Tech 120 program and is a member of the BioIndustry Association and the Knowledge Quarter in London.

Sign up for free to view info

Company overview Employee directory